Fairscale Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Fairscale Capital's BMY Position: Q2 2026 in Review
Fairscale Capital reduced its Bristol-Myers Squibb (BMY) stake by 46% in Q2 2026, selling an estimated $57.4K and leaving 1,197 shares worth $69K. The position accounts for 0.04% of the portfolio, ranked #180.
Fairscale Capital first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. The position peaked at $148K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Fairscale Capital held 1,197 shares of Bristol-Myers Squibb worth $69K as of Q2 2026.
- Fairscale Capital sold 1,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $57.4K.
- Bristol-Myers Squibb made up 0.04% of Fairscale Capital's portfolio in Q2 2026, its #180 holding.
- Fairscale Capital first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
- Fairscale Capital's Bristol-Myers Squibb position peaked at $148K in Q1 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.